Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Aspartase mutant with improved enzyme activity and changed optimal pH

An aspartase and aspartic acid technology, applied in the field of genetic engineering, can solve the problems of harsh pH value conditions, low enzyme activity, and high production cost of β-amino acids, and achieves enhanced capacity and improved specific enzyme activity. Effect

Active Publication Date: 2021-07-16
JIANGNAN UNIV
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the current aspartase has strict requirements on the pH value of the reaction, relies on the reaction environment of high temperature and strong alkali, and has low enzyme activity under mild conditions. This defect leads to high production costs of β-amino acids

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Aspartase mutant with improved enzyme activity and changed optimal pH
  • Aspartase mutant with improved enzyme activity and changed optimal pH
  • Aspartase mutant with improved enzyme activity and changed optimal pH

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0027] Embodiment 1: Contain the recombinant expression vector of the gene encoding aspartase mutant and the construction of recombinant bacteria

[0028] Mutate leucine at position 12 to aspartic acid, tyrosine at position 166 to glutamic acid, glutamine at position 169 to glutamic acid, arginine at position 314 to formazan Thionine, the specific method is: with the pET-21a recombinant plasmid (restriction sites EcoR I and BamH I) containing the nucleotide sequence shown in SEQ ID NO.4 as template, the sequence shown in Table 1 is primer, using The mutant plasmid was constructed by the two-step PCR method of the whole plasmid (the reaction system is shown in Table 2, and the reaction conditions are shown in Table 3), and the gene shown in SEQ ID NO.2 was obtained.

[0029] Table 2 PCR reaction system

[0030]

[0031] Table 3 PCR reaction conditions

[0032]

[0033] The PCR product was checked by gel electrophoresis, and then 1 μL of Dpn I restriction endonuclease wa...

Embodiment 2

[0034] Example 2: Expression of recombinant bacteria pET21a-L12D-Y166E-Q169E-R314M / E.coli BL21

[0035] The recombinant strain pET21a-L12D-Y166E-Q169E-R314M / E.coli BL21 constructed in Example 1 and the control strain pET21a- AspB / E.coli BL21 were inoculated in 10 mL of LB medium containing ampicillin, cultured with shaking at 37°C overnight, until OD 600 0.6-0.9 The next day, transfer to 50mL LB medium containing ampicillin according to 1% inoculation amount, culture at 37°C for 2-3h, then add 0.5mM IPTG and induce at 16°C for 12-16h. The cells were collected by centrifugation at 8000 rpm for 10 min at 4° C. and crushed, and the cell crushed supernatant (crude enzyme liquid) was collected for subsequent purification.

[0036] Purification of aspartase or aspartase mutants is carried out in a hot water bath at 60° C. for 30 minutes, and then centrifuged at 12000 rpm for 90 minutes to obtain the purified enzyme. The obtained purified enzyme was stored at 4°C until use. The pu...

Embodiment 3

[0037] Example 3: Aspartase activity assay and HPLC detection of β-aminobutyric acid

[0038] The enzyme activity of the original enzyme and the mutant enzyme was measured at 70°C and pH 7.0, 8.0, 9.0, and 10.0. After reacting for 1 hour, the content of the product β-aminobutyric acid was measured by HPLC.

[0039] HPLC: Take 100 μL reaction solution, add 40 μL 1M NaHCO 3 After mixing, add 160 μL of 2,4-dinitrofluorobenzene (20.48 mg dissolved in 3 mL of acetone), react in the dark at 60 ° C for 1 h, take it out and centrifuge, and filter with a 0.22 μ membrane. Then inject. Chromatographic column: dimosoil C18 (5μL, 250mm×4.6mm), mobile phase: A: 0.1% formic acid aqueous solution, B: 100% acetonitrile, detector: UVDetector, detection wavelength: 360nm, column temperature: 25°C, injection volume: 10 μL, flow rate: 1.0 mL / min. Process: 0~22min: 15%B→50%B; 22~22.1min: 50%B→15%B; 22.1~26min: 15%B.

[0040] The calculated specific enzyme activities of the original enzyme and t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides an aspartase mutant with improved enzyme activity and changed optimal pH and belongs to the technical field of genetic engineering. An amino acid sequence of the aspartase mutant is shown in SEQ ID NO. 1. According to the aspartase mutant provided by the invention, based on aspartase derived from Bacillus sp. YM55-1, a 12-th leucine is mutated into aspartic acid, a 166-th tyrosine is mutated into glutamic acid, a 169-th glutamine is mutated into glutamic acid, and 314-th arginine is mutated into methionine, so that the pH adaptability of the enzyme is improved, meanwhile, the beta-aminobutyric acid synthesis capability of the enzyme is enhanced, and thus, the industrial production of beta-aminobutyric acid is facilitated.

Description

technical field [0001] The invention relates to an aspartase mutant with improved enzyme activity and changed optimum pH, belonging to the technical field of genetic engineering. Background technique [0002] β-amino acids are widely used target molecules in the pharmaceutical industry and are the structural units of biologically active compounds or natural products and drugs. Among them, β-aminobutyric acid is a potent elicitor that confers broad-spectrum disease protection in at least 40 plant species. In addition, β-aminobutyric acid can be used as the precursor substance of the pharmaceutical intermediate β-aminobutanol, which is the antineoplastic drug 4-methylcyclophosphamide, penem antibiotics and the treatment of AIDS integrase inhibitor drug dulute The key intermediate of Dolutegravir. [0003] The natural substrate of aspartase is aspartic acid, which was selected for the preparation of β-amino acids with high substrate specificity and the characteristics of the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N9/88C12N15/60C12N15/70C12N1/21C12P13/04C12R1/19
CPCC12N9/88C12N15/70C12P13/04C12Y403/01001
Inventor 饶志明王雅玲杨套伟徐美娟张显邵明龙
Owner JIANGNAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products